| Income Statement |
| Total Revenue | 49.85M |
|
| Revenues (USD) | 49.85M |
| Cost of Revenue | 46.59M |
| Gross Profit | 3.26M |
| Operating Expenses | 32.05M |
| Research and Development Expense | 3.20M |
| Selling, General and Administrative Expense | 19.94M |
| Operating Income | -28.78M |
| Interest Expense | 2.78M |
| Income Tax Expense | 619.00K |
| Net Income | -23.26M |
| Net Income Common Stock | -23.26M |
| Net Income Common Stock (USD) | -23.26M |
| Consolidated Income | -23.26M |
| Earnings per Basic Share | -0.28 |
| Earnings per Basic Share (USD) | -0.28 |
| Earnings per Diluted Share | -0.28 |
| Earning Before Interest & Taxes (EBIT) | -19.87M |
| Earning Before Interest & Taxes (USD) | -19.87M |
| Weighted Average Shares | 82.89M |
| Weighted Average Shares Diluted | 82.89M |
| Balance Sheet |
| Cash and Equivalents | 153.42M |
| Cash and Equivalents (USD) | 153.42M |
| Trade and Non-Trade Receivables | 40.28M |
| Current Assets | 248.49M |
| Property, Plant & Equipment Net | 105.42M |
| Total Assets | 392.94M |
| Debt Current | 33.03M |
| Total Debt | 125.11M |
| Current Liabilities | 98.65M |
| Debt Non-Current | 92.09M |
| Total Liabilities | 200.47M |
| Accumulated Retained Earnings (Deficit) | -1.10B |
| Shareholders Equity | 192.46M |
| Shareholders Equity (USD) | 192.46M |
| Assets Non-Current | 144.44M |
| Total Debt (USD) | 125.11M |
| Deferred Revenue | 35.27M |
| Inventory | 27.95M |
| Liabilities Non-Current | 101.82M |
| Trade and Non-Trade Payables | 20.96M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.17M |
| Net Cash Flow from Financing | -4.16M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -22.16M |
| Capital Expenditure | -1.80M |
| Issuance (Purchase) of Equity Shares | 370.00K |
| Issuance (Repayment) of Debt Securities | -4.52M |
| Net Cash Flow from Investing | -1.80M |
| Net Cash Flow from Operations | -16.20M |
| Share Based Compensation | 1.87M |